视频 康希诺宇学峰：2025年穿越“死亡之谷”，成功“摘U”

Core Insights - The core viewpoint of the article is that CanSino (688185.SH) has successfully achieved profitability by the third quarter of 2025, overcoming significant challenges in the biopharmaceutical innovation and research development sector [2]. Company Summary - CanSino's co-founder, chairman, and CEO, Yu Xuefeng, announced the company's profitability milestone during an interview on a financial program [2]. - The company plans to continue increasing its investments to ensure long-term returns for its investors [2].